Analyst II, Business Development at Tarsus Pharamceuticals

Irvine, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Undergraduate degree in Life Sciences (biochemistry, biology, bioengineering, or other related field) or masters in biotechnology
2-4 years of work experience in biotech or pharma innovation, business development, life sciences consulting, equity research, or buy-side role (a plus)
Self-motivation and an affinity for a start-up, entrepreneurial environment
Creativity, overcoming obstacles and can-do approach
Ability to critically evaluate scientific literature
Strong written and oral communication skills
Ability to operate at both strategic and tactical levels
Ophthalmic industry experience (a plus)
Initiative and "self-starter" attitude

Responsibilities

Participate in the evaluation and assessment of key opportunities for the US and key international markets
Perform detailed scientific, commercial, and clinical analysis of new asset opportunities
Engage with cross-functional teams in conducting due diligence of business ideas to ensure proper fit within the broader organization
Present decks cogently summarizing analyses and recommendations relating to the business development landscape for particular indications
Gather competitive analysis, and lead assigned secondary market research as directed
Perform strategic and financial analyses, decision support and analyzing new business initiatives
Initiate and further develop business relationships
Participate in the structuring, drafting, and negotiating of term sheets and agreements, partnering with Legal, BD, Finance, and others
Contribute to a culture of innovation, translation, and entrepreneurship within Tarsus

Skills

Market Analysis

Due Diligence

Financial Analysis

Strategic Analysis

Competitive Intelligence

Contract Negotiation

Data Analysis

Scientific Analysis

Clinical Analysis

Commercial Analysis

Tarsus Pharamceuticals

Develops treatments for eye care diseases

About Tarsus Pharamceuticals

Tarsus Pharmaceuticals develops treatments for diseases that lack effective solutions, focusing mainly on eye care and infectious diseases. Their key product, XDEMVY, is an FDA-approved eye drop solution used to treat Demodex Blepharitis, a condition affecting the eyelids. The company is also working on other potential treatments for conditions such as Lyme Disease Prevention, Meibomian Gland Disease, and Rosacea. Tarsus differentiates itself from competitors by concentrating on specific medical needs and maintaining a strong pipeline of future products. Their goal is to provide effective treatments for patients suffering from these conditions while ensuring compliance with regulations and ethical standards.

Irvine, CaliforniaHeadquarters

2017Year Founded

$58.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in ophthalmic treatments challenges Tarsus's market position.

Potential clinical trial delays could affect Tarsus's product pipeline.

Supply chain constraints may hinder XDEMVY's production and distribution.

Differentiation

Tarsus focuses on high unmet needs in ophthalmic and infectious diseases.

Their lead product, XDEMVY, is FDA-approved for Demodex blepharitis treatment.

Tarsus's pipeline includes innovative treatments for Lyme disease and Rosacea.

Upsides

Growing awareness of Demodex blepharitis expands market for Tarsus's XDEMVY.

Telemedicine rise offers new marketing opportunities for Tarsus's products.

FDA's focus on unmet needs may expedite Tarsus's pipeline approvals.

Land your dream remote job 3x faster with AI

Try Jobo Free